Ca2+ as a mediator of ischemic preconditioning

Hiroshi Miyawaki, Muhammad Ashraf

Research output: Contribution to journalArticle

108 Citations (Scopus)

Abstract

We tested the hypothesis that elevation of [Ca2+](i) during ischemic preconditioning (IPC) stimulates protein kinase C (PKC), which confers the protection against the ischemic injury. Langendorff-perfused rat hearts were subjected to 40-minute global ischemia followed by 30-minute reperfusion (I/R). In preconditioned groups, hearts were subjected to either IPC, consisting of 5-minute global ischemia and 10-minute reperfusion, or high- Ca2+ preconditioning (HCPC), ie, the 5-minute perfusion of higher Ca2+ perfusate (2.3 mmol/L Ca2+) followed by 10-minute perfusion of normal perfusate (1.8 mmol/L Ca2+), and then were subjected to I/R. A significant functional recovery and decreased lactate dehydrogenase release were observed in HCPC and IPC hearts compared with ischemic control hearts. ATP contents of preconditioned hearts were significantly higher than those of the ischemic control hearts. The cell structure in preconditioned hearts was preserved better than that in the ischemic control hearts. Furthermore, the activation and translocation of PKC from cytoplasm to sarcolemma were observed in the preconditioned hearts. Verapamil administered during IPC significantly attenuated the salutary effects of IPC. Administration of chelerythrine a specific PKC inhibitor, completely abolished the HCPC- and IPC-induced cardioprotection. The translocation of PKC by IPC was blocked by verapamil or chelerythrine. Immunohistochemical study using rabbit polyclonal antibody against PKC isoforms indicated that stress induced by IPC or HCPC evoked the translocation of PKCα and PKCδ to the cell membrane. Translocation of PKC isoforms was attenuated by the treatment with verapamil or chelerythrine. These results demonstrate that (I) a transient increase in [Ca2+](i) during IPC is an important trigger for the activation of PKC, which is responsible for cardioprotection; (2) the elevation of [Ca2+](i) during IPC, at least partly, resulted from Ca2+ entry via voltage-dependent Ca2+ channel; and (3) activation and translocation of PKCα and PKCδ occur during IPC and HCPC and may be important in preconditioning.

Original languageEnglish (US)
Pages (from-to)790-799
Number of pages10
JournalCirculation research
Volume80
Issue number6
DOIs
StatePublished - Jan 1 1997
Externally publishedYes

Fingerprint

Ischemic Preconditioning
Protein Kinase C
Verapamil
Reperfusion
Protein Isoforms
Ischemia
Perfusion
Sarcolemma
Protein C Inhibitor
Protein Kinase Inhibitors
L-Lactate Dehydrogenase
Cytoplasm
Adenosine Triphosphate
Cell Membrane

Keywords

  • intracellular Ca
  • ischemia
  • preconditioning
  • protein kinase C

ASJC Scopus subject areas

  • Physiology
  • Cardiology and Cardiovascular Medicine

Cite this

Ca2+ as a mediator of ischemic preconditioning. / Miyawaki, Hiroshi; Ashraf, Muhammad.

In: Circulation research, Vol. 80, No. 6, 01.01.1997, p. 790-799.

Research output: Contribution to journalArticle

Miyawaki, Hiroshi ; Ashraf, Muhammad. / Ca2+ as a mediator of ischemic preconditioning. In: Circulation research. 1997 ; Vol. 80, No. 6. pp. 790-799.
@article{fc8135e7f3ce44d28b6d876007361804,
title = "Ca2+ as a mediator of ischemic preconditioning",
abstract = "We tested the hypothesis that elevation of [Ca2+](i) during ischemic preconditioning (IPC) stimulates protein kinase C (PKC), which confers the protection against the ischemic injury. Langendorff-perfused rat hearts were subjected to 40-minute global ischemia followed by 30-minute reperfusion (I/R). In preconditioned groups, hearts were subjected to either IPC, consisting of 5-minute global ischemia and 10-minute reperfusion, or high- Ca2+ preconditioning (HCPC), ie, the 5-minute perfusion of higher Ca2+ perfusate (2.3 mmol/L Ca2+) followed by 10-minute perfusion of normal perfusate (1.8 mmol/L Ca2+), and then were subjected to I/R. A significant functional recovery and decreased lactate dehydrogenase release were observed in HCPC and IPC hearts compared with ischemic control hearts. ATP contents of preconditioned hearts were significantly higher than those of the ischemic control hearts. The cell structure in preconditioned hearts was preserved better than that in the ischemic control hearts. Furthermore, the activation and translocation of PKC from cytoplasm to sarcolemma were observed in the preconditioned hearts. Verapamil administered during IPC significantly attenuated the salutary effects of IPC. Administration of chelerythrine a specific PKC inhibitor, completely abolished the HCPC- and IPC-induced cardioprotection. The translocation of PKC by IPC was blocked by verapamil or chelerythrine. Immunohistochemical study using rabbit polyclonal antibody against PKC isoforms indicated that stress induced by IPC or HCPC evoked the translocation of PKCα and PKCδ to the cell membrane. Translocation of PKC isoforms was attenuated by the treatment with verapamil or chelerythrine. These results demonstrate that (I) a transient increase in [Ca2+](i) during IPC is an important trigger for the activation of PKC, which is responsible for cardioprotection; (2) the elevation of [Ca2+](i) during IPC, at least partly, resulted from Ca2+ entry via voltage-dependent Ca2+ channel; and (3) activation and translocation of PKCα and PKCδ occur during IPC and HCPC and may be important in preconditioning.",
keywords = "intracellular Ca, ischemia, preconditioning, protein kinase C",
author = "Hiroshi Miyawaki and Muhammad Ashraf",
year = "1997",
month = "1",
day = "1",
doi = "10.1161/01.RES.80.6.790",
language = "English (US)",
volume = "80",
pages = "790--799",
journal = "Circulation Research",
issn = "0009-7330",
publisher = "Lippincott Williams and Wilkins",
number = "6",

}

TY - JOUR

T1 - Ca2+ as a mediator of ischemic preconditioning

AU - Miyawaki, Hiroshi

AU - Ashraf, Muhammad

PY - 1997/1/1

Y1 - 1997/1/1

N2 - We tested the hypothesis that elevation of [Ca2+](i) during ischemic preconditioning (IPC) stimulates protein kinase C (PKC), which confers the protection against the ischemic injury. Langendorff-perfused rat hearts were subjected to 40-minute global ischemia followed by 30-minute reperfusion (I/R). In preconditioned groups, hearts were subjected to either IPC, consisting of 5-minute global ischemia and 10-minute reperfusion, or high- Ca2+ preconditioning (HCPC), ie, the 5-minute perfusion of higher Ca2+ perfusate (2.3 mmol/L Ca2+) followed by 10-minute perfusion of normal perfusate (1.8 mmol/L Ca2+), and then were subjected to I/R. A significant functional recovery and decreased lactate dehydrogenase release were observed in HCPC and IPC hearts compared with ischemic control hearts. ATP contents of preconditioned hearts were significantly higher than those of the ischemic control hearts. The cell structure in preconditioned hearts was preserved better than that in the ischemic control hearts. Furthermore, the activation and translocation of PKC from cytoplasm to sarcolemma were observed in the preconditioned hearts. Verapamil administered during IPC significantly attenuated the salutary effects of IPC. Administration of chelerythrine a specific PKC inhibitor, completely abolished the HCPC- and IPC-induced cardioprotection. The translocation of PKC by IPC was blocked by verapamil or chelerythrine. Immunohistochemical study using rabbit polyclonal antibody against PKC isoforms indicated that stress induced by IPC or HCPC evoked the translocation of PKCα and PKCδ to the cell membrane. Translocation of PKC isoforms was attenuated by the treatment with verapamil or chelerythrine. These results demonstrate that (I) a transient increase in [Ca2+](i) during IPC is an important trigger for the activation of PKC, which is responsible for cardioprotection; (2) the elevation of [Ca2+](i) during IPC, at least partly, resulted from Ca2+ entry via voltage-dependent Ca2+ channel; and (3) activation and translocation of PKCα and PKCδ occur during IPC and HCPC and may be important in preconditioning.

AB - We tested the hypothesis that elevation of [Ca2+](i) during ischemic preconditioning (IPC) stimulates protein kinase C (PKC), which confers the protection against the ischemic injury. Langendorff-perfused rat hearts were subjected to 40-minute global ischemia followed by 30-minute reperfusion (I/R). In preconditioned groups, hearts were subjected to either IPC, consisting of 5-minute global ischemia and 10-minute reperfusion, or high- Ca2+ preconditioning (HCPC), ie, the 5-minute perfusion of higher Ca2+ perfusate (2.3 mmol/L Ca2+) followed by 10-minute perfusion of normal perfusate (1.8 mmol/L Ca2+), and then were subjected to I/R. A significant functional recovery and decreased lactate dehydrogenase release were observed in HCPC and IPC hearts compared with ischemic control hearts. ATP contents of preconditioned hearts were significantly higher than those of the ischemic control hearts. The cell structure in preconditioned hearts was preserved better than that in the ischemic control hearts. Furthermore, the activation and translocation of PKC from cytoplasm to sarcolemma were observed in the preconditioned hearts. Verapamil administered during IPC significantly attenuated the salutary effects of IPC. Administration of chelerythrine a specific PKC inhibitor, completely abolished the HCPC- and IPC-induced cardioprotection. The translocation of PKC by IPC was blocked by verapamil or chelerythrine. Immunohistochemical study using rabbit polyclonal antibody against PKC isoforms indicated that stress induced by IPC or HCPC evoked the translocation of PKCα and PKCδ to the cell membrane. Translocation of PKC isoforms was attenuated by the treatment with verapamil or chelerythrine. These results demonstrate that (I) a transient increase in [Ca2+](i) during IPC is an important trigger for the activation of PKC, which is responsible for cardioprotection; (2) the elevation of [Ca2+](i) during IPC, at least partly, resulted from Ca2+ entry via voltage-dependent Ca2+ channel; and (3) activation and translocation of PKCα and PKCδ occur during IPC and HCPC and may be important in preconditioning.

KW - intracellular Ca

KW - ischemia

KW - preconditioning

KW - protein kinase C

UR - http://www.scopus.com/inward/record.url?scp=0030612657&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0030612657&partnerID=8YFLogxK

U2 - 10.1161/01.RES.80.6.790

DO - 10.1161/01.RES.80.6.790

M3 - Article

C2 - 9168781

AN - SCOPUS:0030612657

VL - 80

SP - 790

EP - 799

JO - Circulation Research

JF - Circulation Research

SN - 0009-7330

IS - 6

ER -